@Manual{R,
    title = {R: A Language and Environment for Statistical Computing},
    author = {{R Core Team}},
    organization = {R Foundation for Statistical Computing},
    address = {Vienna, Austria},
    year = {2020},
    url = {https://www.R-project.org/},
}

@Article {mrbase,
article_type = {journal},
title = {The MR-Base platform supports systematic causal inference across the human phenome},
author = {Hemani, Gibran and Zheng, Jie and Elsworth, Benjamin and Wade, Kaitlin H and Haberland, Valeriia and Baird, Denis and Laurin, Charles and Burgess, Stephen and Bowden, Jack and Langdon, Ryan and Tan, Vanessa Y and Yarmolinsky, James and Shihab, Hashem A and Timpson, Nicholas J and Evans, David M and Relton, Caroline and Martin, Richard M and Davey Smith, George and Gaunt, Tom R and Haycock, Philip C},
editor = {Loos, Ruth},
volume = 7,
year = 2018,
month = {may},
pub_date = {2018-05-30},
pages = {e34408},
citation = {eLife 2018;7:e34408},
doi = {10.7554/eLife.34408},
url = {https://doi.org/10.7554/eLife.34408},
abstract = {Results from genome-wide association studies (GWAS) can be used to infer causal relationships between phenotypes, using a strategy known as 2-sample Mendelian randomization (2SMR) and bypassing the need for individual-level data. However, 2SMR methods are evolving rapidly and GWAS results are often insufficiently curated, undermining efficient implementation of the approach. We therefore developed MR-Base (http://www.mrbase.org): a platform that integrates a curated database of complete GWAS results (no restrictions according to statistical significance) with an application programming interface, web app and R packages that automate 2SMR. The software includes several sensitivity analyses for assessing the impact of horizontal pleiotropy and other violations of assumptions. The database currently comprises 11 billion single nucleotide polymorphism-trait associations from 1673 GWAS and is updated on a regular basis. Integrating data with software ensures more rigorous application of hypothesis-driven analyses and allows millions of potential causal relationships to be efficiently evaluated in phenome-wide association studies.},
keywords = {causal inference, Mendelian randomization, GWAS},
journal = {eLife},
issn = {2050-084X},
publisher = {eLife Sciences Publications, Ltd},
}


@Article{ramsahai_causal_2012,
  title = {Causal {{Bounds}} and {{Observable Constraints}} for {{Non}}-Deterministic {{Models}}},
  author = {Roland R. Ramsahai},
  year = {2012},
  month = {mar},
  volume = {13},
  pages = {829--848},
  issn = {1532-4435},
  abstract = {Conditional independence relations involving latent variables do not necessarily imply observable independences. They may imply inequality constraints on observable parameters and causal bounds, which can be used for falsification and identification. The literature on computing such constraints often involve a deterministic underlying data generating process in a counterfactual framework. If an analyst is ignorant of the nature of the underlying mechanisms then they may wish to use a model which allows the underlying mechanisms to be probabilistic. A method of computation for a weaker model without any determinism is given here and demonstrated for the instrumental variable model, though applicable to other models. The approach is based on the analysis of mappings with convex polytopes in a decision theoretic framework and can be implemented in readily available polyhedral computation software. Well known constraints and bounds are replicated in a probabilistic model and novel ones are computed for instrumental variable models without non-deterministic versions of the randomization, exclusion restriction and monotonicity assumptions respectively.},
  file = {/Users/ralphtrane/Zotero/storage/TKQFENFZ/Ramsahai - 2012 - Causal Bounds and Observable Constraints for Non-d.pdf},
  journal = {J. Mach. Learn. Res.},
  keywords = {causal bounds,convex polytope,directed acyclic graph,instrumental inequality,instrumental variables,latent variables},
}
@Article{balke_bounds_1997,
  title = {Bounds on {{Treatment Effects}} from {{Studies}} with {{Imperfect Compliance}}},
  author = {Alexander Balke and Judea Pearl},
  date = {1997-09-01},
  journaltitle = {Journal of the American Statistical Association},
  volume = {92},
  pages = {1171--1176},
  publisher = {{Taylor \& Francis}},
  issn = {0162-1459},
  doi = {10.1080/01621459.1997.10474074},
  url = {https://doi.org/10.1080/01621459.1997.10474074},
  urldate = {2020-02-05},
  abstract = {This article establishes nonparametric formulas that can be used to bound the average treatment effect in experimental studies in which treatment assignment is random but subject compliance is imperfect. The bounds provided are the tightest possible, given the distribution of assignments, treatments, and responses. The formulas show that even with high rates of noncompliance, experimental data can yield useful and sometimes accurate information on the average effect of a treatment on the population.},
  file = {/Users/ralphtrane/Zotero/storage/JF75VRHA/Balke and Pearl - 1997 - Bounds on Treatment Effects from Studies with Impe.pdf;/Users/ralphtrane/Zotero/storage/57K4SMWL/01621459.1997.html},
  keywords = {Causal models,Latent variables,Linear programming,Noncompliance},
  number = {439},
}
@Article{swanson_partial_2018,
  title = {Partial {{Identification}} of the {{Average Treatment Effect Using Instrumental Variables}}: {{Review}} of {{Methods}} for {{Binary Instruments}}, {{Treatments}}, and {{Outcomes}}},
  shorttitle = {Partial {{Identification}} of the {{Average Treatment Effect Using Instrumental Variables}}},
  author = {Sonja A. Swanson and Miguel A. Hern{\a'a}n and Matthew Miller and James M. Robins and Thomas S. Richardson},
  year = {2018},
  month = {apr},
  volume = {113},
  pages = {933--947},
  issn = {0162-1459, 1537-274X},
  doi = {10.1080/01621459.2018.1434530},
  file = {/Users/ralphtrane/Zotero/storage/5MRFCCXQ/Swanson et al. - 2018 - Partial Identification of the Average Treatment Ef.pdf;/Users/ralphtrane/Zotero/storage/X2HSVIGM/Swanson et al. - 2018 - Partial Identification of the Average Treatment Ef.pdf},
  journal = {Journal of the American Statistical Association},
  language = {en},
  number = {522},
}
@TechReport{balke_nonparametric_1993,
  title = {Nonparametric {{Bounds}} on {{Causal Effects}} from {{Partial Compliance Data}}},
  author = {Alexander Balke and Judea Pearl},
  year = {1993},
  institution = {{JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION}},
  abstract = {Experimental studies in which treatment assignment is random but subject compliance is imperfect may be susceptible to bias; the actual effect of the treatment may deviate appreciably from the mean difference between treated and untreated subjects. This paper establishes universal formulas that can be used to bound the actual treatment effect in any experiment for which compliance data is available and in which the assignment influences the response only through the treatment given. Using a linear programming analysis, we present formulas that provide the tightest bounds that can be inferred on the average treatment effect, given an empirical distribution of assignments, treatments, and responses. The application of these results is demonstrated on data that relates cholesterol levels to cholestyramine treatment ([Lipid Research Clinic Program 84]).},
  file = {/Users/ralphtrane/Zotero/storage/ULJNNXXD/Balke and Pearl - 1993 - Nonparametric Bounds on Causal Effects from Partia.pdf;/Users/ralphtrane/Zotero/storage/VFPBZ8ZA/Balke and Pearl - 1993 - Nonparametric Bounds on Causal Effects from Partia.pdf;/Users/ralphtrane/Zotero/storage/NM26JFVY/summary.html},
}
@Article{ramsahai_causal_2010,
  title = {Causal {{Bounds}} and {{Instruments}}},
  author = {Roland R Ramsahai},
  year = {2010},
  pages = {8},
  abstract = {Instrumental variables have proven useful, in particular within the social sciences and economics, for making inference about the causal effect of a random variable, B, on another random variable, C, in the presence of unobserved confounders. In the case where relationships are linear, causal effects can be identified exactly from studying the regression of C on A and the regression of B on A, where A is the instrument. In the more general case, bounds have been developed in the literature for the causal effect of B on C, given observational data on the joint distribution of C, B and A. Using an approach based on the analysis of convex polytopes, we develop bounds for the same causal effect when given data on (C, A) and (B, A) only. The bounds developed are thus in direct analogy to the standard use of instruments in econometrics, but we make no assumption of linearity. Use of the bounds is illustrated for experiments with partial compliance. The bounds are, for example, relevant in genetic epidemiology, where the `Mendelian instrument' S represents a genotype, and where joint data on all of C, B and A may rarely be available but studies involving pairs of these may be abundant. Other examples of bounding causal effects are considered to show that the method applies to DAGs in general, subject to certain conditions.},
  file = {/Users/ralphtrane/Zotero/storage/QGC8TNW5/Ramsahai - Causal Bounds and Instruments.pdf},
  language = {en},
}
@Article{assarf_computing_2017,
  title = {Computing Convex Hulls and Counting Integer Points with Polymake},
  author = {Benjamin Assarf and Ewgenij Gawrilow and Katrin Herr and Michael Joswig and Benjamin Lorenz and Andreas Paffenholz and Thomas Rehn},
  year = {2017},
  month = {mar},
  volume = {9},
  pages = {1--38},
  issn = {1867-2957},
  doi = {10.1007/s12532-016-0104-z},
  abstract = {The main purpose of this paper is to report on the state of the art of computing integer hulls and their facets as well as counting lattice points in convex polytopes. Using the polymake system we explore various algorithms and implementations. Our experience in this area is summarized in ten ``rules of thumb''.},
  file = {/Users/ralphtrane/Zotero/storage/HP65LXZ5/Assarf et al. - 2017 - Computing convex hulls and counting integer points.pdf},
  journal = {Mathematical Programming Computation},
  language = {en},
  number = {1},
}
@Article{wootton_evidence_2019,
  title = {Evidence for Causal Effects of Lifetime Smoking on Risk for Depression and Schizophrenia: A {{Mendelian}} Randomisation Study},
  shorttitle = {Evidence for Causal Effects of Lifetime Smoking on Risk for Depression and Schizophrenia},
  author = {Robyn E. Wootton and Rebecca C. Richmond and Bobby G. Stuijfzand and Rebecca B. Lawn and Hannah M. Sallis and Gemma M. J. Taylor and Gibran Hemani and Hannah J. Jones and Stanley Zammit and George Davey Smith and Marcus R. Munaf{\a`o}},
  year = {2019},
  month = {sep},
  pages = {1--9},
  publisher = {{Cambridge University Press}},
  issn = {0033-2917, 1469-8978},
  doi = {10.1017/S0033291719002678},
  abstract = {BackgroundSmoking prevalence is higher amongst individuals with schizophrenia and depression compared with the general population. Mendelian randomisation (MR) can examine whether this association is causal using genetic variants identified in genome-wide association studies (GWAS).MethodsWe conducted two-sample MR to explore the bi-directional effects of smoking on schizophrenia and depression. For smoking behaviour, we used (1) smoking initiation GWAS from the GSCAN consortium and (2) we conducted our own GWAS of lifetime smoking behaviour (which captures smoking duration, heaviness and cessation) in a sample of 462690 individuals from the UK Biobank. We validated this instrument using positive control outcomes (e.g. lung cancer). For schizophrenia and depression we used GWAS from the PGC consortium.ResultsThere was strong evidence to suggest smoking is a risk factor for both schizophrenia (odds ratio (OR) 2.27, 95\% confidence interval (CI) 1.67\textendash 3.08, p {$<$} 0.001) and depression (OR 1.99, 95\% CI 1.71\textendash 2.32, p {$<$} 0.001). Results were consistent across both lifetime smoking and smoking initiation. We found some evidence that genetic liability to depression increases smoking ({$\beta$} = 0.091, 95\% CI 0.027\textendash 0.155, p = 0.005) but evidence was mixed for schizophrenia ({$\beta$} = 0.022, 95\% CI 0.005\textendash 0.038, p = 0.009) with very weak evidence for an effect on smoking initiation.ConclusionsThese findings suggest that the association between smoking, schizophrenia and depression is due, at least in part, to a causal effect of smoking, providing further evidence for the detrimental consequences of smoking on mental health.},
  file = {/Users/ralphtrane/Zotero/storage/D2KDMQFT/Wootton et al. - Evidence for causal effects of lifetime smoking on.pdf;/Users/ralphtrane/Zotero/storage/RWUWESCR/AA82945360EC59FEC4331A7A567309C9.html},
  journal = {Psychological Medicine},
  keywords = {ALSPAC,depression,Mendelian randomisation,schizophrenia,smoking,tobacco,UK Biobank},
  language = {en},
}
@Article{davies_reading_2018,
  title = {Reading {{Mendelian}} Randomisation Studies: A Guide, Glossary, and Checklist for Clinicians},
  shorttitle = {Reading {{Mendelian}} Randomisation Studies},
  author = {Neil M. Davies and Michael V. Holmes and George Davey Smith},
  year = {2018},
  month = {jul},
  volume = {362},
  publisher = {{British Medical Journal Publishing Group}},
  issn = {0959-8138, 1756-1833},
  doi = {10.1136/bmj.k601},
  abstract = {{$<$}p{$>$}Mendelian randomisation uses genetic variation as a natural experiment to investigate the causal relations between potentially modifiable risk factors and health outcomes in observational data. As with all epidemiological approaches, findings from Mendelian randomisation studies depend on specific assumptions. We provide explanations of the information typically reported in Mendelian randomisation studies that can be used to assess the plausibility of these assumptions and guidance on how to interpret findings from Mendelian randomisation studies in the context of other sources of evidence{$<$}/p{$>$}},
  chapter = {Research Methods \&amp; Reporting},
  copyright = {Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/.},
  file = {/Users/ralphtrane/Zotero/storage/LALQ25VF/Davies et al. - 2018 - Reading Mendelian randomisation studies a guide, .pdf;/Users/ralphtrane/Zotero/storage/VBBTW8FZ/bmj.html},
  journal = {BMJ},
  language = {en},
  pmid = {30002074},
}
@Article{richardson_ace_2014,
  title = {{{ACE Bounds}}; {{SEMs}} with {{Equilibrium Conditions}}},
  author = {Thomas S. Richardson and James M. Robins},
  year = {2014},
  month = {aug},
  volume = {29},
  pages = {363--366},
  issn = {0883-4237},
  doi = {10.1214/14-STS485},
  abstract = {Discussion of {"}Instrumental Variables: An Econometrician's Perspective{"} by Guido W. Imbens [arXiv:1410.0163].},
  archiveprefix = {arXiv},
  eprint = {1410.0470},
  eprinttype = {arxiv},
  file = {/Users/ralphtrane/Zotero/storage/X2SYAD3M/Richardson and Robins - 2014 - ACE Bounds\; SEMs with Equilibrium Conditions.pdf;/Users/ralphtrane/Zotero/storage/YQ3SAQVT/1410.html},
  journal = {Statistical Science},
  keywords = {Statistics - Methodology},
  number = {3},
}
@InProceedings{ramsahai_causal_2007,
  title = {Causal {{Bounds}} and {{Instruments}}},
  booktitle = {Proceedings of the {{Twenty}}-{{Third Conference}} on {{Uncertainty}} in {{Artificial Intelligence}}},
  author = {Roland R. Ramsahai},
  year = {2007},
  pages = {310--317},
  publisher = {{AUAI Press}},
  address = {{Arlington, Virginia, United States}},
  abstract = {Instrumental variables have proven useful, in particular within the social sciences and economics, for making inference about the causal effect of a random variable, B, on another random variable, C, in the presence of unobserved confounders. In the case where relationships are linear, causal effects can be identified exactly from studying the regression of C on A and the regression of B on A, where A is the instrument. In the more general case, bounds have been developed in the literature for the causal effect of B on C, given observational data on the joint distribution of C, B and A. Using an approach based on the analysis of convex polytopes, we develop bounds for the same causal effect when given data on (C,A) and (B, A) only. The bounds developed are thus in direct analogy to the standard use of instruments in econometrics, but we make no assumption of linearity. Use of the bounds is illustrated for experiments with partial compliance. The bounds are, for example, relevant in genetic epidemiology, where the 'Mendelian instrument' S represents a genotype, and where joint data on all of C, B and A may rarely be available but studies involving pairs of these may be abundant. Other examples of bounding causal effects are considered to show that the method applies to DAGs in general, subject to certain conditions.},
  isbn = {978-0-9749039-3-4},
  series = {{{UAI}}'07},
}
@Article{marigorta_replicability_2018,
  title = {Replicability and {{Prediction}}: Lessons and Challenges from {{GWAS}}},
  shorttitle = {Replicability and {{Prediction}}},
  author = {Urko M. Marigorta and Juan Antonio Rodr√¨guez and Greg Gibson and Arcadi Navarro},
  year = {2018},
  month = {jul},
  volume = {34},
  pages = {504--517},
  issn = {0168-9525},
  doi = {10.1016/j.tig.2018.03.005},
  abstract = {Since the publication of the Wellcome Trust Case Control Consortium (WTCCC) landmark study a decade ago, genome-wide association studies (GWAS) have led to the discovery of thousands of risk variants involved in disease aetiology. This successful story has two angles that are often overlooked. First, GWAS findings are highly replicable. This is an unprecedented phenomenon in complex trait genetics, and indeed in many areas of science, which in past decades had been plagued by false positives. At a time of increasing concerns about the lack of reproducibility, we examine the biological and methodological reasons that account for the replicability of GWAS and identify the challenges ahead. In contrast to the exemplary success at disease gene discovery, at present GWAS findings are not useful to predict phenotypes. We close with an overview of the prospects for individualized prediction of disease risk and its foreseeable impact in clinical practice.},
  file = {/Users/ralphtrane/Zotero/storage/HLIN9VI7/Marigorta et al. - 2018 - Replicability and Prediction lessons and challeng.pdf},
  journal = {Trends in genetics : TIG},
  number = {7},
  pmcid = {PMC6003860},
  pmid = {29716745},
}
@Misc{noauthor_mendelian_nodate,
  title = {Mendelian Randomization: {{Using}} Genes as Instruments for Making Causal Inferences in Epidemiology - {{Lawlor}} - 2008 - {{Statistics}} in {{Medicine}} - {{Wiley Online Library}}},
  file = {/Users/ralphtrane/Zotero/storage/XL4P6D2V/sim.html},
  howpublished = {https://onlinelibrary.wiley.com/doi/abs/10.1002/sim.3034?casa\_token=tbL7k1w7wL8AAAAA\%3AcFBTu9Hozio8TwCTNbZDhoYGbRhCs97Osih7-ate2m9VHmXj\_Cg3UCdunKR-nbn5\_AQa1sUBKsc49g},
}
@Article{lawlor_mendelian_2008,
  title = {Mendelian Randomization: Using Genes as Instruments for Making Causal Inferences in Epidemiology},
  shorttitle = {Mendelian Randomization},
  author = {Debbie A. Lawlor and Roger M. Harbord and Jonathan A. C. Sterne and Nic Timpson and George {Davey Smith}},
  year = {2008},
  month = {apr},
  volume = {27},
  pages = {1133--1163},
  issn = {0277-6715},
  doi = {10.1002/sim.3034},
  abstract = {Observational epidemiological studies suffer from many potential biases, from confounding and from reverse causation, and this limits their ability to robustly identify causal associations. Several high-profile situations exist in which randomized controlled trials of precisely the same intervention that has been examined in observational studies have produced markedly different findings. In other observational sciences, the use of instrumental variable (IV) approaches has been one approach to strengthening causal inferences in non-experimental situations. The use of germline genetic variants that proxy for environmentally modifiable exposures as instruments for these exposures is one form of IV analysis that can be implemented within observational epidemiological studies. The method has been referred to as 'Mendelian randomization', and can be considered as analogous to randomized controlled trials. This paper outlines Mendelian randomization, draws parallels with IV methods, provides examples of implementation of the approach and discusses limitations of the approach and some methods for dealing with these.},
  file = {/Users/ralphtrane/Zotero/storage/D54R8S5S/Lawlor et al. - 2008 - Mendelian randomization using genes as instrument.pdf},
  journal = {Statistics in Medicine},
  keywords = {Bias,Causality,Epidemiologic Methods,Genetic Diseases; Inborn,Genome; Human,Genotype,Humans,Models; Econometric,Molecular Epidemiology,Randomized Controlled Trials as Topic},
  language = {eng},
  number = {8},
  pmid = {17886233},
}
@Article{erlich_routes_2014,
  title = {Routes for Breaching and Protecting Genetic Privacy},
  author = {Yaniv Erlich and Arvind Narayanan},
  year = {2014},
  month = {jun},
  volume = {15},
  pages = {409--421},
  publisher = {{Nature Publishing Group}},
  issn = {1471-0064},
  doi = {10.1038/nrg3723},
  abstract = {Privacy breaching techniques can work by cross-referencing two or more pieces of information to gain new, potentially harmful, knowledge on individuals or their families. Broadly speaking, the main routes to breach privacy are identity tracing, attribute disclosure attacks using DNA (ADAD) and completion of sensitive DNA information.Identity tracing exploits quasi-identifiers in the DNA data or metadata to uncover the identity of an unknown genetic data set. ADAD links the identity of a known person to a sensitive phenotype using DNA-derived data. Completion techniques also work on known DNA data and aim to uncover sensitive genomic areas that were masked to protect the participant.In the past few years, the range of techniques and tools to carry out privacy breaching attacks has expanded. Although most of these techniques are currently beyond the reach of the general public, they can be implemented by trained persons with varying degrees of effort and success.There is considerable debate regarding risk management. Some support a pragmatic, ad-hoc approach of privacy by obscurity, whereas others support a systematic, mathematical approach of privacy by design. Privacy-by-design algorithms include access control, differential privacy and cryptographic techniques.So far, data custodians of genetic databases have primarily adopted access control as a mitigation strategy. New developments in cryptographic methods may usher in additional 'security-by-design' techniques.},
  copyright = {2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.},
  file = {/Users/ralphtrane/Zotero/storage/YL7K442L/Erlich and Narayanan - 2014 - Routes for breaching and protecting genetic privac.pdf;/Users/ralphtrane/Zotero/storage/HES55B6F/nrg3723.html},
  journal = {Nature Reviews Genetics},
  language = {en},
  number = {6},
}

@Article{fuller_privacy_1999,
  title = {Privacy in {{Genetics Research}}},
  author = {B. P. Fuller and M. J. Ellis Kahn and P. A. Barr and L. Biesecker and E. Crowley and J. Garber and M. K. Mansoura and P. Murphy and J. Murray and J. Phillips and K. Rothenberg and M. Rothstein and J. Stopfer and G. Swergold and B. Weber and F. S. Collins and K. L. Hudson},
  year = {1999},
  month = {aug},
  volume = {285},
  pages = {1359--1361},
  publisher = {{American Association for the Advancement of Science}},
  issn = {0036-8075, 1095-9203},
  doi = {10.1126/science.285.5432.1359},
  abstract = {Rapid advances in genetics research and the emerging applications to medical practice have heightened public awareness and public concerns about who will have access to this information and how it will be used. In addition to concerns about the privacy of genetic information maintained in medical records, however, is the concern about the privacy of genetics information maintained in experimental research records. This article presents the National Action Plan on Breast Cancer (NAPBC) recommendations to protect the privacy of experimental genetics research records.},
  chapter = {Policy Forum},
  copyright = {\textcopyright{} 1999 American Association for the Advancement of Science},
  file = {/Users/ralphtrane/Zotero/storage/445F7Z97/1359.html},
  journal = {Science},
  language = {en},
  number = {5432},
  pmid = {10490410},
}

@Article{wang_genome_2017,
  title = {Genome Privacy: Challenges, Technical Approaches to Mitigate Risk, and Ethical Considerations in the {{United States}}},
  shorttitle = {Genome Privacy},
  author = {Shuang Wang and Xiaoqian Jiang and Siddharth Singh and Rebecca Marmor and Luca Bonomi and Dov Fox and Michelle Dow and Lucila Ohno-Machado},
  year = {2017},
  month = {jan},
  volume = {1387},
  pages = {73--83},
  issn = {0077-8923},
  doi = {10.1111/nyas.13259},
  abstract = {Accessing and integrating human genomic data with phenotypes is important for biomedical research. Making genomic data accessible for research purposes, however, must be handled carefully to avoid leakage of sensitive individual information to unauthorized parties and improper use of data. In this article, we focus on data sharing within the scope of data accessibility for research. Current common practices to gain biomedical data access are strictly rule based, without a clear and quantitative measurement of the risk of privacy breaches. In addition, several types of studies require privacy-preserving linkage of genotype and phenotype information across different locations (e.g., genotypes stored in a sequencing facility and phenotypes stored in an electronic health record) to accelerate discoveries. The computer science community has developed a spectrum of techniques for data privacy and confidentiality protection, many of which have yet to be tested on real-world problems. In this article, we discuss clinical, technical, and ethical aspects of genome data privacy and confidentiality in the United States, as well as potential solutions for privacy-preserving genotype\textendash phenotype linkage in biomedical research.},
  file = {/Users/ralphtrane/Zotero/storage/FS4LIMC2/Wang et al. - 2017 - Genome privacy challenges, technical approaches t.pdf},
  journal = {Annals of the New York Academy of Sciences},
  number = {1},
  pmcid = {PMC5266631},
  pmid = {27681358},
}
@Article{beck_gwas_2020,
  title = {{{GWAS Central}}: A Comprehensive Resource for the Discovery and Comparison of Genotype and Phenotype Data from Genome-Wide Association Studies},
  shorttitle = {{{GWAS Central}}},
  author = {Tim Beck and Tom Shorter and Anthony J. Brookes},
  year = {2020},
  month = {jan},
  volume = {48},
  pages = {D933-D940},
  issn = {1362-4962},
  doi = {10.1093/nar/gkz895},
  abstract = {The GWAS Central resource provides a toolkit for integrative access and visualization of a uniquely extensive collection of genome-wide association study data, while ensuring safe open access to prevent research participant identification. GWAS Central is the world's most comprehensive openly accessible repository of summary-level GWAS association information, providing over 70 million P-values for over 3800 studies investigating over 1400 unique phenotypes. The database content comprises direct submissions received from GWAS authors and consortia, in addition to actively gathered data sets from various public sources. GWAS data are discoverable from the perspective of genetic markers, genes, genome regions or phenotypes, via graphical visualizations and detailed downloadable data reports. Tested genetic markers and relevant genomic features can be visually interrogated across up to sixteen multiple association data sets in a single view using the integrated genome browser. The semantic standardization of phenotype descriptions with Medical Subject Headings and the Human Phenotype Ontology allows the precise identification of genetic variants associated with diseases, phenotypes and traits of interest. Harmonization of the phenotype descriptions used across several GWAS-related resources has extended the phenotype search capabilities to enable cross-database study discovery using a range of ontologies. GWAS Central is updated regularly and available at https://www.gwascentral.org.},
  file = {/Users/ralphtrane/Zotero/storage/TPPSDQLW/Beck et al. - 2020 - GWAS Central a comprehensive resource for the dis.pdf},
  journal = {Nucleic Acids Research},
  keywords = {Computational Biology,Databases; Genetic,Gene Ontology,Genome-Wide Association Study,Genomics,Genotype,Phenotype,Software,Software Design,User-Computer Interface,Web Browser},
  language = {eng},
  number = {D1},
  pmcid = {PMC7145571},
  pmid = {31612961},
}
@Article{robins_analysis_1989,
  title = {The {{Analysis}} of {{Randomized}} and {{Nonrandomized AIDS Treatment Trials Using A New Approach}} to {{Causal Inference}} in {{Longitudinal Studies}}},
  author = {James M Robins},
  year = {1989},
  pages = {113--159},
  file = {/Users/ralphtrane/Zotero/storage/GFGGYHTY/nchsr.pdf},
  journal = {Health Service Research Methodology: A Focus On AIDS},
}
@Article{manski_nonparametric_1990,
  title = {Nonparametric {{Bounds}} on {{Treatment Effects}}},
  author = {Charles F. Manski},
  year = {1990},
  volume = {80},
  pages = {319--323},
  issn = {0002-8282},
  file = {/Users/ralphtrane/Zotero/storage/ZB9JG77S/Manski - 1990 - Nonparametric Bounds on Treatment Effects.pdf},
  journal = {The American Economic Review},
  number = {2},
}
